The Moroccan Capital Market Authority (AMMC) approved on 28 October 2026 the prospectus for the stock market listing of Laprophan, a Moroccan pharmaceutical laboratory.
The offering is worth up to MAD 2,222,535,700. It combines a capital increase of 4,105,500 new shares with the sale of up to 2,412,200 existing shares, at MAD 341 per share. A discount is planned for the group’s employees and managers.
The subscription period runs from 9 to 17 November 2026, until 3:30 pm. The shares will be listed on the Casablanca Stock Exchange’s main compartment A.
Sources: AMMC, communiqué : introduction en bourse de Laprophan, October 28, 2026; Le360, IPO Laprophan : ce qu'il faut savoir sur l'opération de 2,22 milliards de dirhams, October 28, 2026.